Cargando…

A comparison between clinical decision support system and clinicians in breast cancer

OBJECTIVE: We are building a clinical decision support system (CSCO AI) for breast cancer patients to improve the efficiency of clinical decision-making. We aimed to assess cancer treatment regimens given by CSCO AI and different levels of clinicians. METHODS: 400 breast cancer patients were screene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jianbin, Yuan, Yang, Bian, Li, Lin, Qiang, Yang, Hua, Ma, Li, Xin, Ling, Li, Feng, Zhang, Shaohua, Wang, Tao, Liu, Yinhua, Jiang, Zefei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192819/ https://www.ncbi.nlm.nih.gov/pubmed/37215843 http://dx.doi.org/10.1016/j.heliyon.2023.e16059

Ejemplares similares

Novel Anti-HER2 Antibody-Drug Conjugates Versus T-DM1 for HER2-Positive Metastatic Breast Cancer After Tyrosine Kinase Inhibitors Treatment
por: Ji, Chenchen, et al.
Publicado: (2023)

Pyrotinib versus trastuzumab emtansine for HER2-positive metastatic breast cancer after previous trastuzumab and lapatinib treatment: a real-world study
por: Li, Feng, et al.
Publicado: (2021)

Effectiveness of second-line anti-HER2 treatment in HER2-positive metastatic breast cancer patients previously treated with trastuzumab: A real-world study
por: Zhao, Wei, et al.
Publicado: (2020)

Efficacy and clinical outcome of chemotherapy and endocrine therapy as first-line treatment in patients with hormone receptor-positive HER2-negative metastatic breast cancer
por: Yuan, Yang, et al.
Publicado: (2023)

Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification
por: Li, Jianbin, et al.
Publicado: (2022)

Trends in Disparities and Transitions of Treatment in Patients With Early Breast Cancer in China and the US, 2011 to 2021
por: Li, Jianbin, et al.
Publicado: (2023)

Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China
por: Ma, Li, et al.
Publicado: (2020)

Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients
por: Zhang, Shaohua, et al.
Publicado: (2016)

Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker
por: Liu, Yi, et al.
Publicado: (2013)

Clinical Decision Support and Implications for the Clinician Burnout Crisis
por: Jankovic, Ivana, et al.
Publicado: (2020)

Clinician Perspectives on Clinical Decision Support for Familial Hypercholesterolemia
por: Bangash, Hana, et al.
Publicado: (2023)

Chemotherapy or endocrine therapy, first-line treatment for patients with hormone receptor-positive HER2-negative metastatic breast cancer in China: a real-world study
por: Yuan, Yang, et al.
Publicado: (2021)

Clinical outcomes of tucidinostat-based therapy after prior CDK4/6 inhibitor progression in hormone receptor-positive heavily pretreated metastatic breast cancer
por: Zhou, Jinmei, et al.
Publicado: (2022)

ASQ3 and/or the Bayley-III to support clinicians' decision making
por: Mackin, Robin, et al.
Publicado: (2017)

Clinician collaboration to improve clinical decision support: the Clickbusters initiative
por: McCoy, Allison B, et al.
Publicado: (2022)

Safety and Current Status of the COVID-19 Vaccine among Patients with Breast cancer: A Cross-Sectional Study from China
por: Zhang, Shaohua, et al.
Publicado: (2023)

Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial
por: Yang, Yang, et al.
Publicado: (2023)

Assessing the decision quality of artificial intelligence and oncologists of different experience in different regions in breast cancer treatment
por: Han, Chunguang, et al.
Publicado: (2023)

Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial
por: Yang, Yang, et al.
Publicado: (2023)

A survey of factors affecting clinician acceptance of clinical decision support
por: Sittig, Dean F, et al.
Publicado: (2006)

Clinician-centric diagnosis of rare genetic diseases: performance of a gene pertinence metric in decision support for clinicians
por: Segal, Michael M., et al.
Publicado: (2020)

Decision boxes for clinicians to support evidence-based practice and shared decision making: the user experience
por: Giguere, Anik, et al.
Publicado: (2012)

Clinician perspectives on clinical decision support systems in lung cancer: Implications for shared decision‐making
por: Ankolekar, Anshu, et al.
Publicado: (2022)

Prognostic Value of Modified IHC4 Score in Patients with Estrogen Receptor‐Positive Metastatic Breast Cancer
por: Jin, Liang, et al.
Publicado: (2020)

Risk of Trastuzumab-Related Cardiotoxicity in Early Breast Cancer Patients: A Prospective Observational Study
por: Xue, Jian, et al.
Publicado: (2014)

Artificial intelligence and clinical decision support: clinicians’ perspectives on trust, trustworthiness, and liability
por: Jones, Caroline, et al.
Publicado: (2023)

Integrating clinicians, knowledge and data: expert-based cooperative analysis in healthcare decision support
por: Gibert, Karina, et al.
Publicado: (2010)

Factors influencing clinicians' willingness to use an AI-based clinical decision support system
por: Choudhury, Avishek
Publicado: (2022)

Combined transcriptome and metabolome analysis reveal key regulatory genes and pathways of feed conversion efficiency of oriental river prawn Macrobrachium nipponense
por: Ling, Feiyue, et al.
Publicado: (2023)

Efficacy and safety of pyrotinib and radiotherapy vs. pyrotinib-based therapy in patients with HER2(+) breast cancer with brain metastasis: a retrospective cohort study
por: Chen, Jiaxin, et al.
Publicado: (2022)

Conversion of ER, PR, HER2 and Ki-67 and Prognosis in breast cancer metastases to the brain
por: Jiaxin, Chen, et al.
Publicado: (2022)

Goserelin plus endocrine treatments maintained long-term clinical benefit in a male patient with advanced breast cancer
por: Jiang, Hang, et al.
Publicado: (2014)

A novel chemical inhibitor suppresses breast cancer cell growth and metastasis through inhibiting HPIP oncoprotein
por: Li, Pengyun, et al.
Publicado: (2021)

Design and Testing of an EHR-Integrated, Busulfan Pharmacokinetic Decision Support Tool for the Point-of-Care Clinician
por: Abdel-Rahman, Susan M., et al.
Publicado: (2016)

Early Mobilization After Stroke: Do Clinical Practice Guidelines Support Clinicians' Decision-Making?
por: Rethnam, Venesha, et al.
Publicado: (2021)

Clinician Responses to a Clinical Decision Support Advisory for High Risk of Torsades de Pointes
por: Gallo, Tyler, et al.
Publicado: (2022)

Association of higher axillary pathologic complete response rate with breast pathologic complete response after neoadjuvant chemotherapy
por: Zhu, Jiujun, et al.
Publicado: (2020)

An exploratory study on the checkout rate of circulating tumor cells and the prediction of efficacy of neoadjuvant therapy and prognosis in patients with HER-2-positive early breast cancer
por: Zhou, Jinmei, et al.
Publicado: (2022)

Analysis of clinicopathological characteristics and prognostic factors of early‐stage human epidermal growth factor receptor 2 (HER2)‐low breast cancer: Compared with HER2‐0 breast cancer
por: Wu, Qian, et al.
Publicado: (2023)

Protein analysis of extracellular vesicles to monitor and predict therapeutic response in metastatic breast cancer
por: Tian, Fei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o5r8t69btl1nfv0p7cksn4k91g